Back to search
Bladder Urothelial Carcinoma In Situ
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Bladder Urothelial Carcinoma In Situ trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Bladder Urothelial Carcinoma In Situ trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is a two-stage, prospective, single-center observational diagnostic accuracy study evaluating noninvasive urine testing for the detection of urothelial car…
The goal of this clinical trial is to learn if TARA-002 can treat high-grade non-muscle invasive bladder cancer (NMIBC) in BCG-naïve adults 18 years of age or o…
The goal of this clinical trial is to learn whether a combination of two chemotherapy drugs, Gemcitabine and Docetaxel, can treat high-grade non-muscle-invasive…
This is a phase II, open-label, single-arm, multi-center Study conducted in Canada and the United States. Patients with Non-Muscle Invasive Bladder Cancer ("NMI…
This research study is creating a way to collect and store specimens and information from participants who may be at an increased risk of developing cancer, or…
A database has been created and will be used in which data will be collected in electronic format relating to adult patients who underwent one of the following…
This phase II trial studies the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose cancer does not…
This study is being conducted to evaluate the safety and tolerability of UGN-501 administered intravesically in adult participants with recurrent non-muscle inv…